Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib

Saved in:

Bibliographic Details
Published in:	Haematologica (Roma) Vol. 90 Suppl; p. ECR36
Main Authors:	Prebet, Thomas, Tigaud, Isabelle, Hayette, Sandrine, Clapisson, Gilles, Philip, Irène, Michallet, Mauricette, Nicolini, Franck E
Format:	Journal Article
Language:	English
Published:	Italy 01-11-2005
Subjects:	Adult Antimetabolites, Antineoplastic - therapeutic use Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Benzamides Combined Modality Therapy Cytarabine - therapeutic use Drug Resistance, Neoplasm Fusion Proteins, bcr-abl - antagonists & inhibitors Fusion Proteins, bcr-abl - genetics Granulocyte Colony-Stimulating Factor - pharmacology Hematopoietic Stem Cell Mobilization Humans Imatinib Mesylate Interferons - therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Leukemia, Myelogenous, Chronic, BCR-ABL Positive - surgery Leukemia, Myeloid, Chronic-Phase - drug therapy Leukemia, Myeloid, Chronic-Phase - genetics Leukemia, Myeloid, Chronic-Phase - surgery Male Peripheral Blood Stem Cell Transplantation Piperazines - pharmacology Piperazines - therapeutic use Pyrimidines - pharmacology Pyrimidines - therapeutic use Recombinant Proteins - pharmacology Remission Induction Transplantation, Autologous
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	1592-8721